This malaria node of CANTAM2 goes to further enhance the successes of CANTAM1, with institutions being Centre de Recherches de Lambarene,USSA and CIRMF (Gabon), University of Yaounde I and University of Buea (Cameroon), FCRM and IRSSA (RoC). This node is further mentored by University of Tubingen...
The node’s ultimate goals are to integrate and synergize efforts to :
Network amongst partners and improve south-to-south and north-to-south
Assess and compare the prevalence, severity and prognoses of Anti-malaria drug induced hepatotoxicity (DIH) in HIV positive and HIV negative individuals.
Characterize drug sensitive and drug resistant strains which are referred to as “complex infection” in malaria parasite genetic factors that are responsible for delayed parasite clearances during malaria episodes.
Genetic characterization of drug resistances in pathogens; case of PYRAMAX, clinical trial study in Gabon, Cameroon, DRC and RoC.
Pharmacovigilance activities for anti-malarial drugs capacity will be implemented in the Central African zone.
Specific training and support (Master and /or PhD) for phamacovigilance and clinical trial.
Subscribe For Newsletter
Subscribe to our newsletter to receive the latest news on our activities
Let’s fight HIV/AIDS, Malaria, Tuberculosis and NTDs